Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP) Stock Crosses Below Two Hundred Day Moving Average of $4.91

Shares of Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.91 and traded as low as $4.25. Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs shares last traded at $4.25, with a volume of 1,392 shares traded.

The business has a fifty day simple moving average of $4.76 and a 200-day simple moving average of $4.90.

About Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP)

Cyclacel Pharmaceuticals, Inc, a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapacitabine, a novel orally-available nucleoside analog that is in Phase III clinical trial for the front-line treatment of acute myeloid leukemia; and Phase II clinical trial for the treatment of myelodysplastic syndromes.

Featured Article: Book Value Per Share – BVPS

Receive News & Ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs and related companies with MarketBeat.com's FREE daily email newsletter.